Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Specimen Handling 69Magnetic Resonance Spectroscopy 52Biopsy 42pembrolizumab 26Carboplatin 26Cyclophosphamide 25Radiation 24Radiotherapy 23Nivolumab 23Cisplatin 21Paclitaxel 20olaparib 18Etoposide 18Doxorubicin 18Vincristine 17Dexamethasone 17X-Rays 16Immunoglobulin G 15Disulfides 15Cytarabine 15Taxes 14Prednisone 14Platinum 14Leucovorin 14Bevacizumab 141,2-diaminocyclohexaneplatinum II citrate 14durvalumab 13Radiotherapy, Intensity-Modulated 12Ipilimumab 12atezolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × XRP6258 × 30 days × Clear all
NCT03419234 2026-06-03

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
223 enrolled 14 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡